Cholinergic channel activator, ABT-418, enhances delayed response accuracy in rats

Drug Development Research

Volumn 40, Issue 4, 1997, Pages 304-312

  Terry Jr , Alvin V ^a   Buccafusco, J J ^a,b   Decker, M W ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

Behaviour; Cognition; Memory; Nicotinic

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; CHOLINERGIC RECEPTOR AFFECTING AGENT; MECAMYLAMINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY; NONHUMAN; RAT;

EID: 0030841542     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199704)40:4<304::AID-DDR4>3.0.CO;2-N     Document Type: Article

References (47)

1. Abood LG, Salles KS, Maiti A (1988): Structure-activity studies of carbamate and other esters: Agonists and antagonists to nicotine. Pharmacol Biochem Behav 30:403-408.
2. Arneric SP, Anderson DJ, Bannon AW, Briggs CA, Buccafusco JJ, Brioni JD, Cannon JB, Decker MW, Donnelly-Roberts D, Gopalakrishnan M, Holladay MW, Kynel J, Marsh KC, Pauly J, Radek RJ, Rodrigues AD, Sullivan JP (1995a): Preclinical pharmacology of ABT-418: A prototypical cholinergic channel activator for the potential treatment of Alzheimer's disease. CNS Drug Rev 1:1-26.
3. Arneric SP, Sullivan JP, Williams M (1995b): Neuronal nicotinic acetylcholine receptors: novel targets for central nervous system therapeutics. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 95-110.
4. Bannon AW, Decker MW, Williams M, Arneric SP (1995): Psychotherapeutic potential of selective neuronal nicotinic acetylcholine receptor ligands. In Domino EF (ed): "Brain Imaging of Nicotine and Tobacco Smoking." NPP Books, Ann Arbor, MI, pp 311-334.
5. Barlow RB, Johnson O (1989): Relations between structure and nicotine-like activity: X-ray crystal structure and analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. Br J Pharmacol 98:799-808.
6. Brioni JD, Linville DG, Cadman ED, Williams S, Buckley MJ, Anderson DJ, Arneric SP (1991): Classical nicotinic agonists differentially affect cognition, cortical cerebral blood flow (DBF) and dopamine (DA) release. Soc Neurosci Abst 17:1236.
7. Brioni JD, O'Neill AB, Kim DJB, Buckley MJ, Decker MW, Arneric SP (1994): Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J Pharmacol Exp Ther 271:353-361.
8. Brioni JD, Kim DJB, Brodie MS, Decker MW (1995): ABT-418: Discriminative stimulus properties and effect on ventral tegmental cell activity. Psychopharmacology 119:368-375.
9. Buccafusco JJ, Jackson WJ (1991): Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol Aging 12:233-238.
10. Buccafusco JJ, Jackson WJ, Gattu M, Terry AV Jr (1995a): Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: Role of nicotinic receptors. NeuroReport 6:1223-1227.
11. Buccafusco JJ, Jackson WJ, Gattu M, Terry AV Jr, Marsh KC, Decker MW, Arneric SP (1995b): Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: A novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256-266.
12. Bushnell PJ (1990): Modelling working and reference memory in rats: Effects of scopolamine on delayed matching-to-position. Behav Pharmacol 1:419-427.
13. 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
14. Collins AC, Bhat RV, Pauly JR, Marks MJ (1990): Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In Book G, Marsh J (eds): "The Biology of Nicotine Dependence." Ciba Foundation Symposium. West Sussex, England: John Wiley & Sons, pp 68-86.
15. Damaj MI, Creasy KR, Welch SP, Rosecrans JA, Aceto MD, Martin BR (1995): Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Psychopharmacology 120:483-490.
16. Decker MW, Majchrzak MJ, Arneric SP (1993): Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol Biochem Behav 45:571-576.
17. Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim D, Giardina WJ, Wasicak JT, Garvey DS, Williams M, Arneric SP (1994a): (S)-3-Methyl-5-(1-Methyl-2-Pyrrolidinyl)Isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities. II. In vivo characterization. J Pharmacol Exp Ther 270:319-328.
18. Decker MW, Curzon P, Brioni JD, Arneric SP (1994b): Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur J Pharmacol 261:217-222.
19. Decker MW, Buckley MJ, Brioni JD (1994c): Differential effects of pretreatment with nicotine and lobeline on nicotine-induced changes in body temperature and locomotor activity in mice. Drug Dev Res 31:52-58.
20. Dunnett SB, Martel FL (1990): Proactive interference effects on short term memory in rats. I. Basic parameters and drug effects. Behav Neurosci 104:655-665.
21. Elrod K, Buccafusco JJ (1991): Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J Pharmacol Exp Ther 258:403-109.
22. 3H)nicotine binding in human cerebral cortex: Comparison between Alzheimer's disease and the normal. J Neurochem 47:1948-1954.
23. Geller I, Hartmann R, Blum K (1971): Effects of nicotine, nicotine monomethiodide, lobeline, chlordiazepoxide, meprobamate and caffeine on a discrimination task in laboratory rats. Psychopharmacologia 20:355-365.
24. Gellerman LW (1933): Chance order of alternating stimuli in visual discrimination experiments. J Genet Psychol 42:207-208.
25. Giacobini E, DeSarno P, Clark B, McIlhany M (1989): The cholinergic receptor system of the human brain. Neurochemical and pharmacological aspects of aging and Alzheimer's. In Nordberg A (ed): "Progress in Brain Research." Amsterdam: Elsevier, pp 335-343.
26. 3H)dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856.
27. Granon S, Poucet B, Thinus-Blanc C, Changeux JP, Vidal C (1995): Nicotinic and muscarinic receptors in the rat prefrontal cortex: Differential roles in working memory, response selection and effortful processing. Psychopharmacology 119:139-144.
28. Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray J (1992): Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494.
29. Levin ED (1992): Nicotinic systems and cognitive function. Psychopharmacology 108:417-531.
30. Levin ED (1996): Nicotinic agonist and antagonist effects on memory. Drug Dev Res 38:188-195.
31. Levin ED, Rose JE, Abood L (1995): Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 51:369-373.
32. MacLeod NK, James TA, Starr MS (1984): Muscarinic action of acetylcholine in the rat ventromedial thalamic nucleus. Exp Brain Res 55:553-561.
33. Martin EJ, Panickar KS, King MA, Deyrup M, Hunter BE, Wang G, Meyer EM (1994): Cytoprotective actions of 2,4-dimethoxy-benzylidene anbaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev Res 31:135-141.
34. Meyer EM, de Fiebre CM, Hunter BE, Simpkins CE, Frauworth N, de Fiebre NEC (1994): Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31:127-134.
35. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988): Intravenous nicotine in Alzheimer's disease: A pilot stsudy. Psychopharmacology 95:171-175.
36. O'Dell TJ, Christensen BN (1988): Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate and aspartate-induced currents in horizontal cells dissociated from the catfish retina. Neurosci Lett 94:93-98.
37. Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G (1987): Nicotinic receptor abnormalities in Alzheimer's and Parkinsons diseases. J Neurol Neurosurg Psychiatry 50:806-809.
38. Reavill C, Walther B, Stolerman IP, Testa B (1990): Behavioral and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 29:619-624.
39. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989): The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797-800.
40. Schechter M, Rosecrans JA (1972): Nicotine as a discriminative cue in rats: Inability of related drugs to produce a nicotine-like cueing effect. Psychopharmacologia 27:379-387.
41. Squire LR, Zola-Morgan S, Chen SK (1988): Human amnesia and animal models of amnesia: Performance of amnesic patients on tests designed for the monkey. Behav Neurosci 102:210-221.
42. Terry AV Jr, Buccafusco JJ, Jackson WJ (1993): Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav 45:925-929.
43. Terry AV Jr, Buccafusco JJ, Jackson WJ, Zagrodnik S, Evans-Martin FF, Decker MW (1996): Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task. Psychopharmacology 123:172-181.
44. Warburton DM, Wesnes K (1984): Drugs as research tools in psychology: Cholinergic drugs and information processing. Neuropsychobiology 11:121-132.
45. Whitehouse PJ, Martino AM, Antuono PG, Lowenstein P, Coyle JT, Price DL, Kellar KJ (1986): Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371:146-151.
46. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten R (1995): Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514.
47. Woodruff-Pak DS, Li Y, Kem WR (1994): A nicotinic agonist (GTS-21), eye blink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res 645:309-317.